New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
12:33 EDTNDZNordion shareholders approve arrangement with Sterigenics
Nordion announced that its shareholders have approved the special resolution authorizing the previously announced plan of arrangement providing for the acquisition by Sterigenics of all Nordion’s outstanding shares for cash consideration of US$13.00 per share. The Arrangement resolution required the approval of 66 2/3% of the votes cast by Shareholders present in person or represented by proxy at the Annual and Special Meeting of Shareholders. As a result of the postponement of the Meeting to June 6, the hearing on the final order in respect of the Arrangement before the Ontario Superior Court of Justice will now be held on June 11 at 9:30 a.m., 330 University Avenue, Toronto, Ontario. The transaction remains subject to certain closing conditions, including receipt of court approval, all regulatory approvals, such as under competition/antitrust laws and the Investment Canada Act, and the coming into force of certain amendments to the Nordion and Theratronics Divestiture Authorization Act, as more fully described in the Management Information Circular dated April 22. In addition, the transaction is effectively conditional upon Nordion having at closing US$300M of available cash on hand to complete the steps of the transaction. As of the date hereof, Nordion has approximately US$344M of cash and cash equivalents. The transaction is not subject to any financing condition and is expected to close in the second half of calendar 2014.
News For NDZ From The Last 14 Days
Check below for free stories on NDZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 11, 2014
08:07 EDTNDZNordion announces termination of HSR waiting period for Sterigenics acquisition
Nordion announced that on July 10, the Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended with respect to Sterigenics’ proposed acquisition of Nordion and the Canadian Competition Bureau issued a no-action letter pursuant to the Competition Act. The receipt of a no-action letter confirms that the Commissioner of Competition does not intend to challenge the proposed acquisition. The termination of the HSR Act waiting period and the receipt of a no-action letter pursuant to the Competition Act satisfy closing conditions of the proposed acquisition. The transaction remains subject to certain closing conditions, including approval under the Investment Canada Act, and is expected to close in 2H14.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use